Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial

Nicole Sherry, William Hagopian, Johnny Ludvigsson, Jack Wahlen, Robert J. Ferry, Bruce W. Bode, Stephen Aronoff, Christopher M. Holland, David A Carlin, Karen L. King,

The Lancet · 2011 · 489 citations · 15 references

Concepts

References

15